BiotechTube
Home/Larimar Therapeutics/Nancy J. Rusinko, Ph.D.
NJ

Nancy J. Rusinko, Ph.D.

Chief Development Officer and Director

Larimar Therapeutics

Therapeutic Areas

Rare DiseasesNeurologyNeurodegenerative Diseases

Larimar Therapeutics Pipeline

DrugIndicationPhase
CTI-1601 (Nomaxofusp)Friedreich's AtaxiaPhase 2
CTI-1601Friedreich's AtaxiaPhase 1

Leadership Team at Larimar Therapeutics

CB
Carole Ben-Maimon, M.D.
President, Chief Executive Officer, and Director
MR
Michael R. Celano
Chief Financial Officer
JC
John C. McKew, Ph.D.
Chief Scientific Officer
RG
Russell G. Clayton, D.O.
Chief Medical Officer
PG
Peter G. Tombros
Chairman of the Board
MJ
Michael J. Sopko
Director
AI
Andrew I. Sassine, J.D.
Director
DB
David B. Stevens, Ph.D.
Director
View full Larimar Therapeutics profile